PSBP yields 0.78% · ABBV yields 3.06%● Live data
📍 ABBV pulled ahead of the other in Year 1
Combined, PSBP + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PSBP + ABBV for your $10,000?
PSB Holding Corp. operates as the holding company for Provident State Bank, Inc. that provides various banking products and services to individuals, small businesses, associations, and government entities. The company offers checking and savings accounts; and overdraft lines of credit, construction loans, home equity lines of credit, installment loans, residential mortgages, manufactured home loans, unimproved land loans, vehicle and boat loans, residential fixed-rate mortgages, business lines of credit, commercial loans and mortgages, commercial letters of credit, equipment and vehicle loans, and agricultural loans. It also provides cash management services; and personal and business check cards, credit and debit cards, wire transfers, night depository services, notary services, cash advances, e-statement services, safe deposit boxes, automated teller machine services, and bill payment services, as well as direct deposit of payroll and social security checks, and automatic drafts from accounts. In addition, the company offers online, mobile, and telephone banking services. It primarily operates in Caroline, Dorchester, Talbot, and Wicomico counties in Maryland; and Sussex County in Delaware. The company was founded in 1904 and is based in Preston, Maryland.
Full PSBP Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.